| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3040285
Max Phase: Preclinical
Molecular Formula: C31H32N4+2
Molecular Weight: 460.63
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: c1cc2cc(c1)CNc1cc[n+](c3ccccc13)CCCCC[n+]1ccc(c3ccccc31)NC2
Standard InChI: InChI=1S/C31H30N4/c1-6-17-34-19-15-28(26-11-2-4-13-30(26)34)32-22-24-9-8-10-25(21-24)23-33-29-16-20-35(18-7-1)31-14-5-3-12-27(29)31/h2-5,8-16,19-21H,1,6-7,17-18,22-23H2/p+2/b32-28+,33-29+
Standard InChI Key: DICFSEBKAMQKLW-NUOLXNBNSA-P
Associated Targets(Human)
Small conductance calcium-activated potassium channel protein 3 139 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 460.63 | Molecular Weight (Monoisotopic): 460.2616 | AlogP: 5.98 | #Rotatable Bonds: 0 |
| Polar Surface Area: 31.82 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: -3.07 | CX LogD: -3.07 |
| Aromatic Rings: 5 | Heavy Atoms: 35 | QED Weighted: 0.28 | Np Likeness Score: 0.51 |
References
| 1. Yang D, Arifhodzic L, Ganellin CR, Jenkinson DH.. (2013) Further studies on bis-charged tetraazacyclophanes as potent inhibitors of small conductance Ca(2+)-activated K+ channels., 63 [PMID:23685886] [10.1016/j.ejmech.2013.02.029] |
Source
Source(1):